Key result
Higher plasma noradrenaline in children with idiopathic dilated cardiomyopathy correlates with lower LVEF and higher mortality.
Why the study?
Do plasma catecholamine levels correlate with heart failure severity and predict mortality in children with idiopathic dilated cardiomyopathy?
Case-Control (n=40)
No
Do plasma catecholamine levels correlate with heart failure severity and predict mortality in children with idiopathic dilated cardiomyopathy?
Elevated plasma catecholamine levels correlate with disease severity and predict mortality in children with idiopathic dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May inform prognosis in pediatric idiopathic dilated cardiomyopathy; hypothesis-generating and should not yet change practice.
Excessive and sustained sympathetic stimulation favours progression of heart failure, and plasma catecholamine estimation can assess the degree of this stimulation 1. High plasma noradrenaline levels have been reported in children with heart failure but these studies have largely included patients with congenital and valvular heart diseases 2–4. We studied plasma catecholamine levels in children with chronic heart failure from idiopathic dilated cardiomyopathy (IDC), and related these to the severity of heart failure and outcome. Twenty children with chronic heart failure from IDC attending the Paediatric Cardiology Clinic of Sultan Qaboos University Hospital, Muscat, Oman formed the study subjects. The diagnosis of IDC was based on WHO criteria 5, and diseases with similar presentation were excluded 6, however, myocardial biopsy was not performed. Twenty matched children with innocent cardiac murmur were selected from out patient clinic as control. They were healthy, did not have any cardiac symptoms, were normotensive, and had normal chest radiographs, electrocardiograms and echo-Doppler studies. A detailed clinical evaluation including the assessment of growth and medication history was obtained, and clinical severity of heart failure assessed as per Ross classification (Table 1) 2. For the purpose of analysis, class I and II were taken as mild heart failure and class III and IV as severe heart failure. To ensure appropriate selection of patients, objective assessment of systolic cardiac function was also performed by measuring left ventricular ejection fraction (LVEF) on echocardiography. The patients were followed up for a period of 3 years and the clinical outcome was recorded as alive or dead. Plasma noradrenaline and adrenaline levels were measured on blood samples drawn through previously inserted venous catheters. All samples were collected in the morning (10:00 AM to 12:00 Noon) in ethylene diamine triacetate (EDTA) tubes, kept in icebox, protected from sunlight and transported to the laboratory immediately. In order to minimise pain and emotional stress during blood collection, the procedure was explained to the older children and they were allowed to observe the procedure on other children before their turn. Anaesthetic cream was applied to the site of the venepuncture and an hour later a small venous catheter was inserted. Blood samples were drawn from these catheters leaving a 2-h period of rest after the cannulation, and this procedure was followed also for the control group. The plasma was separated within 30 min and stored at −80 °C. The catecholamine assay was performed within 4 weeks of sampling, using High performance liquid chromatography with electrochemical detection. Catecholamines were separated on reverse phase columns, and component retention and peak shape were enhanced by adding ion-pairing reagents to the mobile phase 7. The investigation conforms to the principles outlined in the declaration of Helsinki. Data entry and analysis were preformed using Statistical Package for Social Sciences (SPSS) 9.0 for Windows 2000. Non-parametric tests were applied, and Pearson's correlation coefficient (two-tailed) was used to evaluate associations between continuous variables. P<0.05 was taken as significant. Study patients were aged 1–12 years (median 5 years), included eight males and 12 females (M:F=1:1.5), and did not differ from controls in age or sex (Table 2). The duration of symptoms ranged from 6 months to 3 years (median 1 year), and LVEF 15–38% (median 32%). Nine (45%) patients had severe heart failure clinically, and all showed LVEF<30%. The remaining 11 (55%) had mild heart failure, and LVEF>30%. All patients were on optimum doses of furosemide, digoxin and captopril, and none had received beta-blockers. Levels of plasma noradrenaline and adrenaline compared to controls were significantly higher in patients with heart failure (Table 2), with a certain degree of overlap (Fig. 1). Patients with severe heart failure (clinical and echocardiographic) had higher levels of noradrenaline (2814–11198 pmol/l, median 4214 pmol/l, mean 5151 pmol/l) compared to those with mild heart failure (690–4564 pmol/l, median 1563 pmol/l, mean 2157 pmol/l, P=0.001). Similar difference was also noted with plasma adrenaline levels (P=0.002). Plasma noradrenaline levels in the study patients exhibited a negative correlation with the LVEF (r=−0.77; P=0.001). A similar negative correlation was also found between plasma adrenaline levels and LVEF (r=−0.70; P=0.001). Levels of noradrenaline correlated with the heart rates in both patients and controls (r=0.72, P=0.01; Fig. 2). During the follow up period of 3 years, four/nine patients from the severely affected group died, and these four had shown higher levels of noradrenaline (P=0.001) but not adrenaline (P=0.62), compared to the remaining five who survived. The heart rates at the beginning of the study ranged from 110 to 148 (median 121), and at the end of the study from 90 to 160 (median 111). During follow up, the heart rates increased in the patients who died (145–160, median 150), while they decreased in those remaining alive (90–120, median 107), and the difference in the change in heart rate between live and dead patients was significant (P<0.001). However, the differences in heart rate did not relate significantly to their functional class of heart failure at entry into the study [heart rates in mild heart failure 90–120 (median 100) vs. severe heart failure 100–160 (median 115), P=0.13]. The present study has reaffirmed high plasma levels of both noradrenaline and adrenaline in children with heart failure 1,3,8–10, but is different from other studies due to our inclusion of young children with IDC. Higher levels of these neurohormones were associated with the presence of severe symptoms, lower LVEF and a poor outcome, suggesting a potential prognostic value of these measurements. However, despite all attempts there is a wide range of plasma catecholamine levels and some overlap between the cardiomyopathy group and controls. This could be due to the relatively small number of patients studied, resetting of adrenergic receptors 4 and individual variations. The positive correlation of the catecholamine levels and heart rates in our patients and controls might point to the degree of the resting condition as one of the factors for this wide dispersion of values. The follow up of heart rates in our patients has shown a significant increase in patients with a poor outcome, and, therefore, heart rates may be used during follow-up as a surrogate endpoint for catecholamines.
No takes yet. Share an insight, caveat, or question.
Venugopalan et al. (2003) conducted a case-control in Chronic heart failure from idiopathic dilated cardiomyopathy (IDC) (n=40). Plasma catecholamine levels (noradrenaline and adrenaline) vs. Matched healthy controls with innocent cardiac murmur was evaluated on Correlation of plasma noradrenaline with LVEF and mortality (r=-0.77, p=0.001). Higher plasma noradrenaline levels in children with idiopathic dilated cardiomyopathy correlated with lower LVEF and were elevated in patients who died.
Synapse has enriched 10 related papers. Consider them for comparative context: